Advertisement
Advertisement
U.S. markets open in 5 hours 17 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Bayer Aktiengesellschaft (BAYN.DE)

XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
56.69+1.17 (+2.11%)
As of 09:58AM CEST. Market open.
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close55.52
Open55.98
Bid56.72 x 28400
Ask56.74 x 2100
Day's Range55.88 - 57.03
52 Week Range43.90 - 67.99
Volume417,590
Avg. Volume3,168,825
Market Cap55.694B
Beta (5Y Monthly)1.12
PE Ratio (TTM)25.31
EPS (TTM)2.24
Earnings DateAug 04, 2022
Forward Dividend & Yield2.00 (3.49%)
Ex-Dividend DateMay 02, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for BAYN.DE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • News Direct

      Automated Agricultural Helpers: Ripe for Robots

      View additional multimedia and more ESG storytelling from Bayer on 3blmedia.com

    • News Direct

      A Global Crisis Brings Food Security to the Table

      Every plate of food is the center of a story.

    • Reuters

      UPDATE 2-U.S. Supreme Court again nixes Bayer challenge to weedkiller suits

      The U.S. Supreme Court on Monday rejected another Bayer AG bid to dismiss litigation alleging that its Roundup weedkiller causes cancer as the German pharmaceutical and chemical giant tries to avoid potentially billions of dollars in damages. The justices turned away a Bayer appeal and left in place a lower court decision upholding an $87 million judgment awarded in a lawsuit in California to Alberta and Alva Pilliod, who were diagnosed with cancer after spraying Roundup for more than three decades. The Supreme Court on June 21 rejected a Bayer appeal in a different Roundup case.

    Advertisement
    Advertisement